COVID-19 Complications & Searches for a Cure with Dr. David Ho

Time and time again, the worlds of public health, news, and medicine have merged on the topic of respiratory care. In the last half-decade, matters on vaping effects, rising pollution concerns, and increasing COPD and lung cancer deaths have made headlines.

And in the last 6 months, a respiratory virus has altered global medicine, healthcare and society in unprecedented fashion. Its severity has strained ICU personnel and ventilator resources, and its highly infectious spread has sparked debate over public mask-wearing.

The coronavirus 2019 (COVID-19) pandemic has dramatically and irrevocably tipped over the public’s interest in respiratory health, and clinicians face heightened dual tasks: adapt to new parameters set by the virus, and serve as counselors on the developing research of SARS-CoV-2.

As providers of timely and topline clinical news and insights, HCPLive® should provide content which reflects the new agenda of healthcare.

Introducing Lungcast, a new podcast series produced in collaboration with the American Lung Association (ALA). Hosted by chief medical officer Al Rizzo, MD, FACP, the monthly podcast series will feature interviews with world-leading researchers, clinicians, and healthcare experts on the biggest topics in respiratory care.

Every episode will be made available here on HCPLive, as well as on the ALA’s website. Listeners can also subscribe to Lungcast on Apple Podcasts, Spotify, and Radio.com.

Our first guest is among the most qualified people in medicine to discuss the COVID-19 pandemic: world-leading virologist, AIDS research pioneer, Time 1996 Man of the Year, and current coronavirus investigator David Ho, MD.

In an illustrious four-decade medical career bookended by observing the earliest cases of AIDS at Cedars-Sinai Medical Center and now leading his New York-based laboratory in COVID-19 vaccine pursuits, Ho has a world of perspective to share on epidemic response.

From US response failures to promising monoclonal antibodies, and from the caveats of herd immunity to the similarities between early AIDS discovery and COVID-19, listen in on Ho’s insights into the current pandemic.

Enjoy Lungcast.